Related Experiment Video
Updated: Dec 3, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Protein-Directed Dynamic Combinatorial Chemistry: An Efficient Strategy in Drug Design
Andrea Canal-Martín1, Ruth Pérez-Fernández1
1Structural and Chemical Biology Department, Centro de Investigaciones Biológicas "Margarita Salas", CIB-CSIC, Madrid 28040, Spain.
Protein-directed dynamic combinatorial chemistry (P-DCC) identifies drug ligands by using proteins to select binding compounds from a dynamic library. This amplification process discovers new hit compounds for therapeutic targets.
Area of Science:
- Medicinal Chemistry
- Chemical Biology
- Drug Discovery
Background:
- Protein-directed dynamic combinatorial chemistry (P-DCC) is a powerful method for identifying ligands for protein targets.
- This technique leverages a protein's ability to thermodynamically template ligand binding.
- Ligand binding shifts library composition, amplifying desired affinity molecules.
Purpose of the Study:
- To provide an updated overview of protein-directed DCC applications.
- To discuss fundamental aspects of designing P-DCC experiments.
- To highlight suitable reversible reactions and analytical methodologies.
Main Methods:
- Review of existing literature on P-DCC.
- Analysis of thermodynamic templating effects in ligand discovery.
- Discussion of biocompatible reversible reactions for library synthesis.
- Examination of experimental analysis techniques for P-DCC.
Main Results:
- P-DCC effectively identifies high-affinity ligands for various protein targets.
- The amplification of selected library members is key to hit compound discovery.
- Biocompatible reversible reactions and appropriate analytical methods are crucial for successful P-DCC experiments.
Conclusions:
- Protein-directed DCC is a valuable strategy for discovering novel ligands and drug candidates.
- Careful consideration of reaction chemistry and experimental design enhances P-DCC efficiency.
- This approach accelerates the identification of pharmacologically relevant compounds.
More Related Videos
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drug-Receptor Bonds
In...